We recently compiled a list of the Why These 15 Hardware Stocks Are Skyrocketing So Far in 2025. In this article, we are ...

The deal comes at a time when the Anglo-Swedish pharma company is facing a string of investigations in the country, ...

The fund’s thesis comes during a time when diversity initiatives, programs, and focuses are under political and legal fire.

The FDA posted to its site the observations made during an inspection of an AstraZeneca (AZN) manufacturing center that was conducted from May ...

Reports Q4 revenue $258.4M, consensus $250.1M. “Our strong finish to 2024 was driven by excellent performance in Sealing Technologies and ...

Astrazeneca has defended the £14.7 million pay package handed to chief executive Pascal Soriot, saying the group is too big ...

Shein was valued at as much as $100bn in 2022, but is now reportedly being pushed by its backers to cut its valuation to ...

Before you take the plunge, it’s essential to understand the current investment property rates available. Knowing what kind of interest rate you can expect to pay on your loan—versus a ...

Fast-fashion giant Shein is under investor pressure to slash its valuation by two thirds from its all time high should it go ahead with its long-awaited float on the London Stock Exchange later this ...

Managing editor for Motley Fool Money. James has worked full-time for The Motley Fool since 2012. He's a personal finance wonk, longtime editor, former reporter, and University of Michigan alum.